Stay updated on Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial page.

Latest updates to the Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov site revision label changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check12 days agoChange DetectedA banner announces NIH’s transition from using the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check20 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check26 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page now renders a 403 Forbidden error instead of loading the study details, making the content inaccessible. The additions show the 403 HTML snippet and a Home link, indicating a blocked-access state.SummaryDifference20%

- Check68 days agoChange DetectedThe page revision has been updated from v3.6.5 to v3.6.6. This reflects a new build/version of the page without altering study information shown.SummaryDifference0.0%

Stay in the know with updates to Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial page.